Illimis Therapeutics
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 Heolleung-ro 569-gil, Seoul, 06376, S...Phone Number
+82 24456877Website
www.illimistx.comRevenue
$11.8 MillionIndustry
ZI Rank: 1
About Illimis Therapeutics
Illimis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Illimis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Illimis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Illimis Therapeutics is spiking on competitors!
Illimis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Illimis Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Illimis Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Illimis Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Illimis Therapeutics
Funding: Get notified immidiatlly once Illimis Therapeutics has new funding data
Recommended Actions
Find VP level buyers at Illimis Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Illimis Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Illimis Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Illimis Therapeutics.
Illimis Therapeutics financials insights
Gather financial insights about Illimis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$15.4M
Illimis Therapeutics Tech Stack
A closer look at the technologies used by Illimis Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Illimis Therapeutics
Illimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for neurodegenerative diseases such as Alzheimers. Our platform is differentiated by its ability to address the concerns of antibody-induced neuroinflammation and subsequent ARIA (Amyloid-Related Imaging Abnormalities) often observed from e... Read More
